Zenas BioPharma logo

Zenas BioPharma

Remote Jobs

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

8 open rolesTeam 51-200Latest: May 1, 2026, 2:13 PM UTC
Biotechnology Research
Post Date
Minimum Salary
Experience

8 Jobs

Zenas BioPharma logo

Regional Business Director

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Director28 days ago

Role Description The Regional Business Director (RBD), Immunology, is a critical commercial leadership role responsible for driving sales performance, strategic execution, and customer engagement across a defined geographic region. This includes the design and implementation of business plans based upon strategic business analysis. This leader will manage, coach, and develop a team of high-performing Account Managers (AMs) to ensure exceptional performance in a competitive rare disease, specialty market. The RBD will collaborate cross-functionally to optimize field strategy, enhance customer experience, and support successful launches within the immunology portfolio. This position reports to the SVP, US Commercial Engagement and Access. Key Responsibilities - Regional Leadership & Team Management - Hire, lead, develop, and inspire a team of Account Managers to achieve and exceed regional sales goals. - Establish a high-performance culture focused on accountability, integrity, strategic execution, and professional development. - Develop and implement performance plans to support AM skill growth, capability building, and succession planning. - Conduct regular field rides and coaching sessions to model best practices and reinforce customer-centric engagement. - Ensure compliance with all company policies, legal requirements, and industry standards in all field activities. - Strategic Planning & Execution - Translate national brand strategy into actionable regional business plans tailored to local markets, customer needs, and competitive dynamics. - Leverage market data, customer insights, and analytics to identify opportunities and challenges and adjust strategies accordingly. - Oversee pull-through of brand initiatives, launch plans, and disease-area priorities across the region. - Partner with Marketing, Market Access, Medical Affairs and other internal stakeholders to ensure aligned compliant execution. - Customer & Market Engagement - Establish and maintain relationships with key customers, including HCPs, administrators, and influential institutions across immunology. - Support AMs in developing deeper customer insights and effective territory plans. - Ensure customer needs and marketplace dynamics are communicated to inform strategy, planning, and resource allocation. - Cross-Functional Collaboration - Collaborate closely with Medical Affairs, Market Access, Patient Services, and other functions to ensure coordinated, compliant customer engagement. - Work with leadership to support congress activities, regional events, and speaker programs. - Ensure alignment between regional goals and national commercial priorities. - Operational Excellence - Manage regional budget effectively, including resource allocation, travel, and strategic investments. - Report regional performance trends, strategic recommendations, and competitive insights to senior leadership. Qualifications - Bachelor’s degree required; MBA or advanced degree preferred. - 8+ years of pharmaceutical/biotech commercial experience, with a minimum of 3–5 years leading field sales teams. - Experience in rheumatology, immunology, rare disease, biologics, or specialty care strongly preferred. - Demonstrated success in building, managing, and leading dynamic teams, including performance planning and skill development. - Proven track record of strong sales performance in highly competitive specialty markets. - Strong understanding of payer dynamics, specialty pharmacy distribution models, and access challenges in immunology/biologics. - Excellent strategic thinking, business planning, and analytical skills. - Exceptional communication, coaching, and interpersonal leadership abilities. - Ability to travel extensively across the region. - Talent Developer: Proven ability to coach, elevate, and retain high-potential talent. - Strategic Operator: Strong business acumen with the ability to translate insights into actionable strategies. - Cross-Functional Influencer: Effective at aligning multiple internal stakeholders toward shared objectives. - Customer-Focused Leader: Deep commitment to understanding and addressing customer needs in immunology. - Integrity & Compliance: Models ethical behavior and ensures compliant execution across the region. Benefits - Competitive compensation and benefits package. - Base salary pay range for this role is $187,200 to $234,000. - Annual performance bonus, equity, full range of benefits, and other incentive compensation plans. Company Description Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases.

United States
$187.2K - $234K / year
Zenas BioPharma logo

Associate Director, Medical Science Liaison (MSL), Rheumatology

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Medical Director52 days ago

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor. We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation! Territory: MidAtlantic (NY, NJ, PA, OH) Position Summary: The Associate Director, Medical Science Liaisons (MSLs), Rheumatology, at Zenas are the field-based extension of our Medical Affairs department. MSLs are scientifically-trained professionals who possess strong clinical and/or scientific backgrounds whose role is to be a resource of fair-balanced and scientifically-rigorous information to the healthcare community. This position reports to the Executive National Director, US MSLs. Key Responsibilities: - Identify, establish, and maintain professional relationships and dialogue with international, national, regional, and local key opinion leaders and allied healthcare professionals. - Educate healthcare professionals on Zenas’ product portfolio. - Function as a regional medical/scientific resource and work to pair external stakeholder needs with available Zenas resources. - Demonstrate proficiency in delivering educational resources and clinical information in response to an established need/request. - Liaise with investigators to support clinical research activities (investigator-initiated and company sponsored). - Facilitate speaker development and training. - Engage in timely and fair-balanced scientific exchanges with HCPs in a compliant, ethical manner in response to unsolicited requests for information related to Zenas’ products. - Lead, contribute to, attend, and provide scientific support at international, national, regional, and local medical conferences. - Liaise with Clinical Operations to support company-sponsored studies. - Actively participate in advisory boards and clinical investigator meetings. - Gather data to generate insights and competitive intelligence to provide impactful and appropriate feedback to headquarters based on field interactions with healthcare providers, thought leaders, and congress attendance. - Deliver internal educational training sessions for internal stakeholders, including disease state, therapeutic landscape, and product information. - Build and cultivate working relationships cross-functionally with adherence to compliance guidelines. - Engage in continued independent learning within the therapeutic area - Adherence to all company regulatory and compliance policies - Identify & coordinate execution of scientific communication opportunities at national and local congresses - Work closely with the team to identify opportunities to generate and present meaningful data - Provide scientific session, poster or symposium coverage when requested - Attend face-to-face meetings to gain pertinent feedback from experts Qualifications: - Advanced clinical/science degree or health care professional credentials required (MD, PhD, RPh, PharmD, NP, PA, MS or equivalent) - Minimum 3+ years MSL, field-based, or clinical position preferred - Therapeutic area experience preferred - Knowledge of treatment guidelines, clinical research processes, FDA regulations, and Officer of Inspector General (OIG) guidelines preferred - Outstanding interpersonal skills, including building strong working relationships and managing and resolving conflict - Excellent communication skills (written, verbal, listening, and presentation) - Results-oriented - Team oriented - Proven track record of success - Current knowledge & full understanding of all relevant industry, legal, and regulatory compliance guidelines - Commitment to the highest ethical, legal, regulatory, and scientific standards #LI-Remote Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $181,600 to $227,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location. Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans. Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued. All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.

United States
$181K - $227K / year
Zenas BioPharma logo

Director, Commercial Training

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Medical Director59 days ago

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor. We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation! Position Summary: The Director of Training leads the vision, strategy, and execution of Zenas Bio Pharma training programs, ensuring all commercial field-facing teams are equipped with the knowledge, skills, and capabilities needed to excel. This role oversees the development, integration, and continuous enhancement of training frameworks, curricula, digital learning assets, and capability-building initiatives that support both initial onboarding and ongoing professional development across all commercial functions required for Account Management. The Director provides strategic oversight of vendors and training partners to ensure consistency, quality, and alignment across the commercial field. Working cross-functionally with Commercial Leadership, Medical Leadership, Compliance, Marketing, HR, and Field Leadership, this role translates strategic business priorities into high-impact learning solutions that elevate field performance and drive commercial excellence. This leader guides the development of modern learning systems and processes, identifying capability gaps through data, field insights, and performance metrics. The Director plays a key role in supporting product launch, enhancing field readiness, and strengthening leadership capabilities throughout the organization. Key Responsibilities: - Coordination of the new hire training and ongoing skills/knowledge training across all commercial field-facing teams. - Ensure that the training curriculum and on-boarding processes meet the current and emerging needs of the field-facing employees. - Oversee the development, updating, and use of all training modules that are appropriate for commercial employees. - Create training materials that enhance the learning process; including study guides, home study materials, assessments, frequently asked questions, competitive overviews, etc. - Lead commercial training across all settings which include 1:1 meetings, conference calls, live classroom, etc. - Gather and analyze data from direct field observations, focus groups, and other methods to identify potential training gaps and suggest areas for improvement that will enhance performance and achieve Zenas Bio Pharma goals. - Manage the training of commercial employees on cross functional business rules (ie. Veeva CRM, Concur, Patient Services data/CRM, etc.). Cross Functional Collaboration - Support leadership in leading content development workstreams across field meetings from an objective, content, and agenda standpoint. - Work with the cross-functional teams to gather feedback on training needs and development of necessary meeting workshops to meet those needs. - Work with sales leadership to facilitate management-level “train-the-trainer” sessions. Systems and Employee On-going Personal Development - Create and manage the Learning Management System (LMS), and all vendors related to field training and development resources. - Work with corporate compliance and/or our compliance agency partner to ensure field employees are trained and up to date on policies and procedures that affect their respective functional areas. - Other duties as assigned Qualifications: - Bachelor’s degree (science or business preferred) or equivalent combination of relevant education and applicable job experience may be considered. MBA preferred. - A minimum of 10 years’ progressively responsible experience in pharmaceutical sales and training, with a minimum of 6 years in training. - A focus on Immunology &/or Rare Disease preferred. - Experience with product launches and Account Management experience is highly desired. - Demonstrated leadership and teaching/facilitation ability. - Proven ability in creating effective training materials. - Proven application of adult learning principles. - The ability to successfully navigate challenging situations and conversations with diplomacy, respect and flexibility when required. - Experience in launching a product in a rare disease - Excellent interpersonal and communication skills. - Organization, initiative, and self-motivation. - Project and vendor management experience. - Professionalism, integrity, and the ability to comply with strict policy, work in a highly regulated environment and maintain confidential information and data. - Ability to travel up to 30%. #LI-Remote The position is eligible for a competitive compensation and benefits package. Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $184,000 to $230,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location. Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans. Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued. All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.

United States
$184K - $230K / year
Zenas BioPharma logo

National Account Director, Payer Accounts

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Accounts Payable60 days ago

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor. We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation! Position Summary: The National Account Director, Payer Accounts is responsible for developing and executing payer engagement strategies that support optimal coverage, access, and reimbursement for Zenas BioPharma’s innovative portfolio. Reporting to the Executive Director, Payer Strategy, this role will lead strategic engagement with national payer organizations, Medicare and commercial health plans, pharmacy benefit managers (PBMs), and Tier 1 regional health plans to support optimal coverage and access. The National Account Director will build and manage senior-level relationships with payer decision makers, support formulary positioning and contracting discussions, and ensure payer insights inform internal access strategy. This individual will collaborate closely with cross-functional partners including Pricing & Contracting, Medical Affairs, Sales, Market Access Operations, and Patient Services to ensure payer strategy is aligned with commercial execution and supports successful patient access. The successful candidate will bring established relationships with key national and regional payer organizations and PBMs and demonstrated success negotiating coverage and access for specialty or rare disease therapies. This role offers a unique opportunity to help shape payer access strategy and establish foundational payer partnerships in preparation for upcoming product launches. Key Responsibilities: - Develop and maintain strategic relationships with national payer organizations, Medicare and commercial health plans, pharmacy benefit managers (PBMs), and Tier 1 regional health plans. - Execute payer engagement strategies designed to support favorable coverage, reimbursement pathways, and formulary positioning for Zenas therapies. - Partner with the Executive Director, Payer Strategy to support payer engagement activities leading up to anticipated product launches. - Collaborate with the Sales organization to share payer insights, support field awareness of coverage dynamics, and help address market access barriers impacting providers and patients. - Lead and support payer contract negotiations in collaboration with Finance and the Pricing & Contracting team, ensuring alignment with overall access and reimbursement strategy - Monitor payer coverage policies, utilization management criteria, and competitive access dynamics to inform internal strategy. - Provide actionable payer insights and market intelligence to cross-functional stakeholders including Sales, Medical Affairs, HEOR, Commercial, and Patient Services teams. - Provide strategic payer insights and account-level intelligence to senior leadership to help inform access strategies, coverage planning, and launch readiness. - Support development and delivery of payer value presentations and account engagement plans. - Maintain detailed account plans and track payer coverage developments to ensure coordinated payer strategy across accounts. - Represent Zenas BioPharma with professionalism, credibility, and integrity while building long-term payer partnerships. Qualifications: - The successful candidate will bring deep experience engaging national and regional payer organizations and pharmacy benefit managers, with a demonstrated ability to influence coverage strategy and negotiate access for specialty or rare disease therapies. Experience engaging Medicare Advantage or Part D plans is preferred. - Bachelor’s degree required; advanced degree (MBA, MPH, PharmD or similar) preferred. - Minimum of 10+ years of experience in the pharmaceutical or biotechnology industry, including at least 5 years in Market Access, payer account management, or managed markets roles. - Demonstrated experience negotiating and managing contracts with national payer organizations, PBMs, and Tier 1 regional health plans. - Demonstrated experience managing and growing relationships with national and regional payers, with an established network of payer decision-makers required. - Proven success supporting payer strategy, formulary positioning, and reimbursement planning for specialty, rare disease, or immunology therapies preferred. - Strong understanding of the U.S. payer landscape including commercial health plans, PBMs, specialty pharmacy distribution models, and reimbursement dynamics. - Demonstrated ability to work cross-functionally and influence internal and external stakeholders. - Strong communication, presentation, and strategic planning skills. - Ability to operate effectively in a fast-paced and collaborative biotech environment. - Willingness to travel as required to support payer engagement. #LI-Remote The position is eligible for a competitive compensation and benefits package. Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $196,000 to 245,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location. Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans. Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued. All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.

United States
$196K - $245K / year
Zenas BioPharma logo

Senior Director, Payer Strategy

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Pricing Analyst60 days ago

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor. We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation! Position Summary: The Senior Director, Payer Strategy is responsible for developing and leading the U.S. payer access strategy to support optimal coverage, access, and reimbursement for Zenas BioPharma’s innovative portfolio. Reporting to the Vice President, U.S. Market Access, this role will lead payer strategy development and execution while building and managing relationships with national and regional payer organizations, pharmacy benefit managers (PBMs), and government plans. This role will function as a player-coach, combining strategic leadership with direct payer engagement. This individual will work closely with the National Account Director(s) to establish foundational payer relationships, shape coverage and contracting strategy, and ensure payer insights inform cross-functional planning ahead of anticipated product launches. The Senior Director will collaborate closely with cross-functional partners including Pricing & Contracting, Medical Affairs, Sales, Market Access Operations, Patient Services, and HEOR to ensure a coordinated approach to payer engagement and access strategy. This role offers a unique opportunity to shape payer access strategy and establish foundational payer partnerships in preparation for upcoming product launches.. Key Responsibilities: - Lead the development and execution of the U.S. payer strategy to support optimal coverage, reimbursement, and patient access. - Establish and maintain strategic relationships with national payer organizations, pharmacy benefit managers (PBMs), Medicare plans, and Tier 1 regional health plans. - Serve as a player-coach, directly engaging payer accounts while providing leadership and guidance to the National Account Director(s). - Partner with Finance and Pricing & Contracting to inform payer contracting strategy and support negotiations with payer organizations. - Lead payer engagement planning, ahead of anticipated product launches, including value messaging, payer presentations, and account strategy. - Monitor payer coverage policies, utilization management criteria, and competitive access dynamics to inform internal strategy. - Provide payer insights and market intelligence to senior leadership to support access strategy, pricing decisions, and launch readiness. - Collaborate with Sales leadership to ensure payer insights, support field awareness of coverage dynamics, and help address market access barriers impacting providers and patients. - Partner with Medical Affairs and HEOR to support evidence communication and payer value discussions. - Ensure cross-functional alignment across Market Access, Commercial, and Medical teams to support a coordinated payer strategy. - Represent Zenas BioPharma with professionalism and credibility while building long-term payer partnerships Qualifications: - Minimum of 12+ years of experience in the pharmaceutical or biotechnology industry, including at least 8 + years in Market Access, payer strategy, managed markets, or national account leadership roles. - Deep experience engaging national and regional payer organizations and pharmacy benefit managers (PBMs), with demonstrated success influencing coverage strategy and negotiating access for specialty or rare disease therapies. - Proven experience leading or directly participating in payer contract negotiations with national payer organizations, PBMs, and Tier 1 regional health plans, including experience negotiating formulary positioning, coverage policies, and access terms. - Demonstrated experience developing payer strategies that support successful product launches or late-stage pipeline assets. - Established relationships with key decision makers across national payer organizations, PBMs, and leading regional health plans strongly preferred. - Strong understanding of the U.S. payer landscape including commercial health plans, PBMs, Medicare Advantage, specialty pharmacy distribution models, and reimbursement dynamics. - Experience collaborating cross-functionally with Pricing & Contracting, Medical Affairs, Sales, HEOR, and Patient Services teams to support payer strategy and access planning. - Demonstrated ability to translate payer insights into strategic recommendations that inform pricing strategy, coverage planning, and launch readiness. - Proven leadership capability with experience guiding account strategy and mentoring payer account managers or national account teams. - Bachelor’s degree required; advanced degree (MBA, MPH, PharmD or similar) preferred. - Strong executive communication, presentation, and strategic planning skills. - Ability to operate effectively in a fast-paced and highly collaborative biotech environment. - Willingness to travel as required to support national payer engagement. #LI-Remote The position is eligible for a competitive compensation and benefits package. Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $214,400 to 268,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location. Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans. Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued. All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.

United States
$214K - $268K / year
Zenas BioPharma logo

Senior Director, Access Strategy & Patient Services

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Strategy60 days ago

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor. We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation! Position Summary: The Senior Director, Access Strategy & Patient Services is responsible for designing and leading the patient access strategy to ensure seamless patient services operations to facilitate timely and appropriate access to Zenas BioPharma therapies. Reporting to the Vice President, U.S. Market Access, this role will lead the development of the patient journey strategy, HUB services model, affordability programs, and provider onboarding processes to ensure patients and providers can successfully navigate access to therapy. This individual will play a critical role in establishing the patient access infrastructure ahead of anticipated product launches, lead the establishment and operationalization of the patient support HUB, design the prior authorization support pathways, implement affordability assistance programs, and ensure effective coordination with specialty pharmacy partners to support efficient patient onboarding and therapy initiation. The Senior Director will collaborate closely with cross-functional partners including Market Access Operations, Payer Strategy, Pricing & Contracting, Medical Affairs, Compliance, Legal, and Sales to ensure a coordinated and compliant approach to patient support services. This role offers a unique opportunity to design and implement the patient access ecosystem in preparation for upcoming product launches. Key Responsibilities: - Lead the development and execution of the patient access strategy to support successful product launch and long-term patient access.Review or author statistical analysis sections of protocols, statistical analysis plans (SAP), clinical study reports (CSR), regulatory documents or scientific publications. - Design and map the end-to-end patient journey, identifying access barriers and implementing solutions that support efficient patient onboarding and therapy initiation. - Lead the development, implementation, and operational launch of the patient support HUB program, including vendor selection, program design, operational workflows, and performance management. - Develop and implement prior authorization support pathways that facilitate efficient payer approvals while ensuring compliance with regulatory and legal requirements. - Design and implement patient affordability strategies, including copay assistance programs and financial support resources. - Partner closely with the Trade & Distribution organization and specialty pharmacy partners to ensure efficient coordination of patient onboarding and patient access services. - Collaborate with the Payer Strategy and Pricing & Contracting teams to ensure patient access programs are aligned with payer coverage strategy and reimbursement pathways. - Work closely with Sales leadership to identify provider educational needs to ensure healthcare providers are equipped to navigate patient access processes. - Establish and monitor access performance metrics, including time-to-therapy, patient onboarding timelines, HUB performance including compliance with program business rules, and patient support program effectiveness. - Provide strategic insights to senior leadership regarding patient access barriers and opportunities to improve the patient experience. - Lead and manage relationships with HUB vendors and patient support service partners to ensure high-quality program execution and continuous improvement. - Lead the HUB vendor selection process, including development of RFP requirements, vendor evaluation, and implementation planning. - Partner with Legal, Compliance, Medical Affairs, and Commercial teams to ensure all patient support programs operate in a compliant and patient-focused manner. Qualifications: - Minimum of 12+ years of experience in the pharmaceutical or biotechnology industry, or healthcare services industry, including at least 7+ years in Market Access, patient services, patient support programs, or access strategy roles. - Demonstrated experience designing and implementing patient access programs, including HUB services, benefit verification support, prior authorization pathways, and patient onboarding processes. - Proven experience developing and launching patient support HUB programs supporting specialty or rare disease therapies. - Experience leading the design, vendor selection, and launch of patient support HUB programs supporting specialty or rare disease therapies strongly preferred. - Experience designing and managing patient affordability programs, including copay assistance programs and financial support resources. - Strong understanding of patient access dynamics including benefit verification, prior authorization requirements, payer coverage processes, specialty pharmacy coordination, and reimbursement pathways. - Demonstrated ability to develop patient access strategies that improve patient onboarding and reduce time-to-therapy. - Experience managing external vendors and patient support service partners, including HUB vendors. - Strong cross-functional collaboration skills with experience partnering across Market Access, Trade & Distribution, Payer Strategy, Sales, Medical Affairs, Legal, Compliance, and Commercial organizations. - Experience supporting product launches or late-stage pipeline assets strongly preferred. - Bachelor’s degree required; advanced degree (MBA, MPH, PharmD or similar) preferred. - Strong leadership, communication, and strategic planning skills. - Ability to operate effectively in a fast-paced and collaborative biotech environment. - Willingness to travel as required to support program implementation and stakeholder engagement #LI-Remote The position is eligible for a competitive compensation and benefits package. Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $228,000 to 285,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location. Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans. Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued. All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.

United States
$228K - $285K / year
Zenas BioPharma logo

Senior Director, Pricing & Contracting

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Director60 days ago

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor. We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation! Position Summary: The Senior Director, Pricing & Contracting is responsible for developing and leading the U.S. pricing and contracting strategy to support optimal market access, reimbursement, and financial performance for Zenas BioPharma’s portfolio, including development of contracting strategies with national/regional payer organizations, PBMs, and government payer segments. Reporting to the Vice President, U.S. Market Access, this role will lead the development of pricing strategy, gross-to-net modeling, and payer contracting strategies that support both product launch planning and lifecycle management. The Senior Director will play a key role in establishing launch pricing strategy while also overseeing ongoing pricing governance, access financial modeling, and contracting frameworks with payer organizations, pharmacy benefit managers (PBMs), and other healthcare stakeholders. This individual will work closely with the Payer Strategy team to support contract negotiations and ensure pricing and contracting decisions align with overall market access strategy and company financial objectives. This role will collaborate cross-functionally with Finance, Market Access, Legal, Compliance, Medical Affairs, and Commercial leadership to evaluate pricing scenarios, inform access strategy decisions, and support the successful commercialization of Zenas therapies. This role offers a unique opportunity to shape pricing and contracting strategy in preparation for upcoming product launches while supporting long-term access and financial performance for the Zenas portfolio. Key Responsibilities: - Lead the development and execution of U.S. pricing strategy, including launch price recommendations and lifecycle pricing management for Zenas BioPharma’s portfolio. - Develop and manage gross-to-net (GTN) models that support financial forecasting, access strategy decisions, and pricing scenario planning. - Design and implement payer contracting strategies, including rebate structures and contracting frameworks with pharmacy benefit managers (PBMs), national payer organizations, and regional health plans. - Partner with the Payer Strategy team to support contract negotiations and ensure pricing and rebate strategies align with payer coverage objectives. - Lead financial modeling and pricing scenario analyses to evaluate the impact of pricing and contracting strategies on market access, reimbursement, and overall company financial performance. - Collaborate closely with Finance to ensure pricing assumptions, GTN forecasts, and contracting scenarios are accurately reflected in financial planning and forecasting models. - Monitor competitive pricing dynamics, payer contracting trends, and reimbursement environments to inform pricing strategy and market access planning. - Support the development of pricing governance processes and provide strategic recommendations to senior leadership regarding pricing decisions and contracting strategies. - Provide strategic pricing insights to support launch planning, payer engagement strategy, and long-term market access objectives. - Provide strategic oversight of government pricing considerations, including AMP, Best Price, Medicaid rebate implications, and 340B pricing impacts, ensuring pricing and contracting strategies align with regulatory requirements. - Partner with Legal and Compliance to ensure pricing and contracting practices adhere to regulatory requirements and company compliance standards. - Collaborate cross-functionally with Market Access, Commercial, Medical Affairs, HEOR, and Finance teams to ensure alignment between pricing strategy, access strategy, and commercial objectives. - Support the evaluation of pricing and contracting strategies across different payer segments, including commercial and government payer environments Qualifications: - Minimum of 12+ years of experience in the pharmaceutical or biotechnology industry, including at least 7+ years in Pricing, Contracting, Market Access, or Managed Markets roles. - Demonstrated experience developing U.S. pricing strategy, including launch pricing recommendations and lifecycle pricing management for specialty or rare disease therapies. - Proven experience developing and managing gross-to-net (GTN) models to support financial forecasting, pricing scenario planning, and contracting strategy. - Demonstrated experience designing and implementing payer contracting strategies, including rebate structures and negotiations with pharmacy benefit managers (PBMs), national payer organizations, government payers and regional health plans. - Strong understanding of U.S. pharmaceutical pricing dynamics, including WAC strategy, payer rebates, contracting frameworks, and market access considerations. - Experience evaluating government pricing implications including AMP, Best Price, Medicaid rebate exposure, and 340B pricing considerations. - Experience supporting product launches or late-stage pipeline assets strongly preferred. - Strong financial modeling and analytical skills with the ability to translate complex pricing and contracting scenarios into strategic recommendations. - Demonstrated ability to collaborate cross-functionally with Market Access, Finance, Legal, Compliance, Medical Affairs, and Commercial teams. - Experience supporting pricing governance processes and cross-functional pricing decision frameworks preferred. - Bachelor’s degree required; advanced degree (MBA, MPH, PharmD or similar) preferred. - Strong leadership, communication, and executive presentation skills. - Ability to operate effectively in a fast-paced and collaborative biotech environment. - Willingness to travel as required to support contracting discussions and internal planning #LI-Remote The position is eligible for a competitive compensation and benefits package. Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $219,200 to 274,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location. Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans. Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued. All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.

United States
$219K - $274K / year
Zenas BioPharma logo

Associate Director, Medical Science Liaison (MSL), Rheumatology

Zenas BioPharma

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Advancing two late-stage, potential franchise molecules: obexelimab and orelabrutinib. Obexelimab is designed to inhibit the activity of cells implicated in autoimmune diseases. Orelabrutinib is a highly selective CNS-penetrant, oral, small molecule BTK inhibitor. Earlier stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.

Director162 days ago
OtherRemoteLeadTeam 51-200

This description is a summary of our understanding of the job description. Click on 'Apply' button to find out more. Role Description The Associate Director, Medical Science Liaisons (MSLs), Rheumatology, at Zenas are the field-based extension of our Medical Affairs department. MSLs are scientifically-trained professionals who possess strong clinical and/or scientific backgrounds whose role is to be a resource of fair-balanced and scientifically-rigorous information to the healthcare community. This position reports to the Executive National Director, US MSLs. - Identify, establish, and maintain professional relationships and dialogue with international, national, regional, and local key opinion leaders and allied healthcare professionals. - Educate healthcare professionals on Zenas’ product portfolio. - Function as a regional medical/scientific resource and work to pair external stakeholder needs with available Zenas resources. - Demonstrate proficiency in delivering educational resources and clinical information in response to an established need/request. - Liaise with investigators to support clinical research activities (investigator-initiated and company sponsored). - Facilitate speaker development and training. - Engage in timely and fair-balanced scientific exchanges with HCPs in a compliant, ethical manner in response to unsolicited requests for information related to Zenas’ products. - Lead, contribute to, attend, and provide scientific support at international, national, regional, and local medical conferences. - Liaise with Clinical Operations to support company-sponsored studies. - Actively participate in advisory boards and clinical investigator meetings. - Gather data to generate insights and competitive intelligence to provide impactful and appropriate feedback to headquarters based on field interactions with healthcare providers, thought leaders, and congress attendance. - Deliver internal educational training sessions for internal stakeholders, including disease state, therapeutic landscape, and product information. - Build and cultivate working relationships cross-functionally with adherence to compliance guidelines. - Engage in continued independent learning within the therapeutic area. - Adherence to all company regulatory and compliance policies. - Identify & coordinate execution of scientific communication opportunities at national and local congresses. - Work closely with the team to identify opportunities to generate and present meaningful data. - Provide scientific session, poster or symposium coverage when requested. - Attend face-to-face meetings to gain pertinent feedback from experts. Qualifications - Advanced clinical/science degree or health care professional credentials required (MD, PhD, RPh, PharmD, NP, PA, MS or equivalent). - Minimum 3+ years MSL, field-based, or clinical position preferred. - Therapeutic area experience preferred. - Knowledge of treatment guidelines, clinical research processes, FDA regulations, and Officer of Inspector General (OIG) guidelines preferred. - Outstanding interpersonal skills, including building strong working relationships and managing and resolving conflict. - Excellent communication skills (written, verbal, listening, and presentation). - Results-oriented. - Team oriented. - Proven track record of success. - Current knowledge & full understanding of all relevant industry, legal, and regulatory compliance guidelines. - Commitment to the highest ethical, legal, regulatory, and scientific standards. Requirements - #LI-Remote Benefits - The base salary pay range for this role is $181,600 to $227,000. - Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location. - Zenas believes in providing a competitive compensation and benefits package to all employees. - Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans.

United States
$181.6K - $227K / year
Job Closed